Lumniczky K et al. Simultaneous isolation of both RNA and DNA from many small tissue samples.. (1997) ACTA BIOLOGICA HUNGARICA (1983-2018) 0236-5383 1588-256X 48 253-257,
1702740
Szakcikk (Folyóiratcikk) | Tudományos[1702740]
Köteles Gy. Through the hills and valleys of radiation biology in Hungary.. (2004) CENTRAL EUROPEAN JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE 1219-1221 10 3 202-226
Lumniczky K et al. Carcinogenic alterations in murine liver, lung and uterine tumors induced by in utero exposure to ionizing radiation.. (1998) MOLECULAR CARCINOGENESIS 0899-1987 1098-2744 21 2 100-110,
1702798
Szakcikk (Folyóiratcikk) | Tudományos[1702798]
Gulay K C et al. Effects of Continuous Gamma-Ray Exposure In Utero in B6C3F1 Mice on Gestation Day 18 and at 10 Weeks of Age. (2018) RADIATION RESEARCH 0033-7587 1938-5404 189 4 425-440
Hudson D et al. Induction and persistence of radiation-induced DNA damage is more pronounced in young animals than in old animals. (2011) AGING-US 1945-4589 1945-4589 3 6 609-620
King TJ et al. Deficiency in the gap junction protein Connexin32 alters p27(Kip1) tumor suppression and MAPK activation in a tissue-specific manner. (2005) ONCOGENE 0950-9232 1476-5594 24 10 1718-1726
King TJ et al. Altered tumor biology and tumorigenesis in irradiated and chemical carcinogen-treated single and combined connexin32/p27(Kip1)-deficient mice. (2005) CELL COMMUNICATION AND ADHESION 1541-9061 1543-5180 12 5-6 293-305
King TJ et al. Mice deficient for the gap junction protein Connexin32 exhibit increased radiation-induced tumorigenesis associated with elevated mitogen-activated protein kinase (p44/Erk1, p42/Erk2) activation. (2004) CARCINOGENESIS 0143-3334 1460-2180 25 5 669-680
Zhang SH et al. Genomic instability of murine hepatocellular carcinomas with low and high metastatic capacities. (2004) WORLD JOURNAL OF GASTROENTEROLOGY 1007-9327 2219-2840 10 4 521-524
Pogribny I et al. Dose-dependence, sex- and tissue-specificity, and persistence of radiation-induced genomic DNA methylation changes. (2004) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 320 4 1253-1261
Filkowski J et al. Genotoxicity of 2,4-D and dicamba revealed by transgenic Arabidopsis thaliana plants harboring recombination and point mutation markers. (2003) MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS 1383-5718 1879-3592 542 1-2 23-32
Romanenko A et al. Radiation sclerosing proliferative atypical nephropathy of peritumoral tissue of renal-cell carcinomas after the Chernobyl accident in Ukraine. (2001) VIRCHOWS ARCHIV 0945-6317 1432-2307 438 2 146-153
Hollstein M et al. New approaches to understanding p53 gene tumor mutation spectra. (1999) MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS 0027-5107 1873-135X 1386-1964 431 2 199-209
Schmidt J et al. Onset and dynamics of osteosclerosis in mice induced by RFB murine leukemia virus (RFB MuLV): Increase in bone mass precedes lymphomagenesis.. (1999) AMERICAN JOURNAL OF PATHOLOGY 0002-9440 1525-2191 155 557-570,
1704497
Szakcikk (Folyóiratcikk) | Tudományos[1704497]
van Gaalen SM et al. Use of Fluorochrome Labels in In Vivo Bone Tissue Engineering Research. (2010) TISSUE ENGINEERING PART B REVIEWS 1937-3368 1937-3376 16 2 209-217
Sharma P et al. RANKL-RANK signaling regulates expression of xenotropic and polytropic virus receptor (XPR1) in osteoclasts. (2010) BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS 0006-291X 1090-2104 399 2 129-132
Dabrowska MJ et al. Loss of MicroRNA Targets in the 3 ' Untranslated Region as a Mechanism of Retroviral Insertional Activation of Growth Factor Independence 1. (2009) JOURNAL OF VIROLOGY 0022-538X 1098-5514 83 16 8051-8061
Désaknai S et al. Brain tumor treatment with IL-2 and IL-12 producing autologous cancer cell vaccines.. (2001) ADVANCES IN EXPERIMENTAL MEDICINE AND BIOLOGY 0065-2598 495 369-379,
1704525
Szakcikk (Folyóiratcikk) | Tudományos[1704525]
Yin XL et al. AntiTumor Mechanism of Recombinant Murine Interleukin-12 Vaccine. (2010) CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS 1084-9785 1557-8852 25 3 263-268
Sonabend AM et al. A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma. (2008) ANTI-CANCER DRUGS 0959-4973 1473-5741 19 2 133-142
Lumniczky K et al. Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model. (2002) CANCER GENE THERAPY 0929-1903 1476-5500 9 1 44-52,
154686
Szakcikk (Folyóiratcikk) | Tudományos[154686]
Gamat-Huber Melissa et al. Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC). (2020) CANCERS 2072-6694 12 10
Michels Luana R. et al. HPLC-UV method for temozolomide determination in complex biological matrices: Application for in vitro, ex vivo and in vivo studies. (2019) BIOMEDICAL CHROMATOGRAPHY 0269-3879 1099-0801 33 10
Kumari Sonali et al. Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma. (2018) NANOMEDICINE 1743-5889 1748-6963 13 20 2579-2596
Zenkoh Junko et al. The abscopal effect induced by in situ-irradiated peripheral tumor cells in a murine GL261 brain tumor model. (2017) TRANSLATIONAL CANCER RESEARCH 2218-676X 2219-6803 6 1 136-148
Lee Young Eun et al. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor. (2017) NEURO-ONCOLOGY 1522-8517 1523-5866 19 8 1079-1087
Zhou Wei et al. Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation. (2015) JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY 0171-5216 1432-1335 141 4 575-589
Liu Yawei et al. PD-L1 Expression by Neurons Nearby Tumors Indicates Better Prognosis in Glioblastoma Patients. (2013) JOURNAL OF NEUROSCIENCE 0270-6474 1529-2401 33 35 14231-14245
Revoltella RP et al. Granulocyte-macrophage colony-stimulating factor as an autocrine survival-growth factor in human gliomas. (2012) CYTOKINE 1043-4666 1096-0023 57 3 347-359
Grekova S P et al. Activation of a glioma-specific immune response by oncolytic parvovirus Minute Virus of Mice infection. (2012) CANCER GENE THERAPY 0929-1903 1476-5500 19 7 468-475
Hua W et al. The CD133+ tumor stem-like cell-associated antigen may elicit highly intense immune responses against human malignant glioma. (2011) JOURNAL OF NEURO-ONCOLOGY 0167-594X 1573-7373 105 2 149-157
Janelidze S et al. Immunizations With IFN gamma Secreting Tumor Cells can Eliminate Fully Established and Invasive Rat Gliomas. (2009) JOURNAL OF IMMUNOTHERAPY 1524-9557 1537-4513 32 6 593-601
Maes W et al. DC vaccination with anti-CD25 treatment leads to long-term immunity against experimental glioma. (2009) NEURO-ONCOLOGY 1522-8517 1523-5866 11 5 529-542
Persson BRR et al. Survival of rats with N29 brain tumours after irradiation with 5 or 15 Gy and immunization with IFN-gamma secreting tumour cells. (2008) Megjelent: Proceedings of the International Conference on Biomedical Engineering and Informatics, BMEI 2008: Vol. 2 pp. 243-247
Smith KE et al. Synergism between GM-CSF and IFN gamma: Enhanced immunotherapy in mice with glioma. (2007) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 120 1 75-80
WANG Hao et al. Progress in research on combination treatment of cancer with radiation therapy and immunotherapy. (2007) Bulletin of the Academy of Military Medical Sciences 1000-5501 31 4 391-393,399
Newcomb EW et al. The combination of ionizing radiation and peripheral vaccination produces long-term survival of mice bearing established invasive GL261 gliomas. (2006) CLINICAL CANCER RESEARCH 1078-0432 1557-3265 12 15 4730-4737
Clavreul A et al. Effects of syngeneic cellular vaccinations alone or in combination with GM-CSF on the weakly immunogenic F98 glioma model. (2006) JOURNAL OF NEURO-ONCOLOGY 0167-594X 1573-7373 79 1 9-17
Meng YX et al. Successful combination of local CpG-ODN and radiotherapy in malignant glioma. (2005) INTERNATIONAL JOURNAL OF CANCER 0020-7136 1097-0215 116 6 992-997
Mattei TA et al. Past, present and future perspectives of genetic therapy in gliomas. (2005) INDIAN JOURNAL OF HUMAN GENETICS 0971-6866 1998-362X 11 1 4-13
Sikorski CW et al. Immunotherapy for malignant glioma: current approaches and future directions. (2005) NEUROLOGICAL RESEARCH 0161-6412 1743-1328 27 7 703-716
Kuwashima N et al. Delivery of dendritic cells engineered to secrete IFN-alpha into central nervous system tumors enhances the efficacy of peripheral tumor cell vaccines: Dependence on apoptotic pathways. (2005) JOURNAL OF IMMUNOLOGY 0022-1767 1550-6606 175 4 2730-2740
Demaria S et al. Combining radiotherapy and immunotherapy: A revived partnership. (2005) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 0360-3016 1879-355X 63 3 655-666
Mu Yongju et al. Preliminary Results of Immunotherapy Against Malignant Gliomas Using Autologous Tumor Cell Vaccine. (2004) AIBIAN, JIBIAN, TUBIAN / CARCINOGENESIS, TERATOGENESIS AND MUTAGENESIS 1004-616X 16 4 208-210
Ishikawa E et al. Intratumoral injection of IL-2-activated NK cells enhances the antitumor effect of intradermally injected paraformaldehyde-fixed tumor vaccine in a rat intracranial brain tumor model. (2004) CANCER SCIENCE: THE OFFICIAL JOURNAL OF THE JAPANESE CANCER ASSOCIATION 1347-9032 1349-7006 95 1 98-103
Li JH et al. Inhibition or promotion of tumor growth by granulocyte-macrophage colony stimulating factor derived from engineered tumor cells is dose-dependent. (2004) ANTICANCER RESEARCH 0250-7005 1791-7530 24 5A 2717-2721
Jean WC et al. Effects of combined granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-2, and interleukin-12 based immunotherapy against intracranial glioma in the rat. (2004) JOURNAL OF NEURO-ONCOLOGY 0167-594X 1573-7373 66 1-2 39-49
Quatan N et al. Cellular immunotherapy for concepts and clinical cancer: Current perspectives scientific basis and approaches for therapeutic cancer vaccines: Part I. (2004) CLINICAL ONCOLOGY 0936-6555 1433-2981 16 5 356-365
Walker PR et al. T-cell immune response's in the brain and their relevance for cerebral malignancies. (2003) BRAIN RESEARCH REVIEWS 0165-0173 42 2 97-122
Désaknai S et al. Local tumour irradiation enhances the anti-tumour effect of a double-suicide gene therapy system in a murine glioma model.. (2003) JOURNAL OF GENE MEDICINE 1099-498X 1521-2254 5 377-385,
1704533
Szakcikk (Folyóiratcikk) | Tudományos[1704533]
Michels Luana R. et al. HPLC-UV method for temozolomide determination in complex biological matrices: Application for in vitro, ex vivo and in vivo studies. (2019) BIOMEDICAL CHROMATOGRAPHY 0269-3879 1099-0801 33 10
Lee Young Eun et al. Repositioning disulfiram as a radiosensitizer against atypical teratoid/rhabdoid tumor. (2017) NEURO-ONCOLOGY 1522-8517 1523-5866 19 8 1079-1087
Medina Luis-Alberto et al. Use of an orthovoltage X-ray treatment unit as a radiation research system in a small-animal cancer model. (2008) JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH 0392-9078 1756-9966 27
Faneca H et al. Evaluation of the antitumoral effect mediated by IL-12 and HSV-tk genes when delivered by a novel lipid-based system. (2007) BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES 0005-2736 1879-2642 1768 5 1093-1102
Wang Xiangling et al. Antitumor effects of cytosine deaminase and thymidine kinase fusion suicide gene under the control of mdr1 promoter in mdr1 positive leukemia cells. (2007) LEUKEMIA & LYMPHOMA 1042-8194 1029-2403 48 8 1600-1609
WANG Kiangling et al. Study on the targeted killing effects of CD-TK double suicide genes driven by mdr1 promoter on multidrug-resistant K562 cell line in vitro. (2006) ZHONGHUA XUEYEXUE ZAZHI / CHINESE JOURNAL OF HEMATOLGY 0253-2727 27 11 757-761
Song Y et al. Procaspase-3 enhances the in vitro effect of cytosine deaminase-thymidine kinase disuicide gene therapy on human ovarian cancer. (2006) INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER 1048-891X 1525-1438 16 1 156-164
MA Yi et al. Efficacy of denovirus-mediated double suicide gene combined with prodrugs for treatment of human hepatocellular carcinoma. (2006) ZHONGHUA SHIYAN WAIKE ZAZHI / CHINESE JOURNAL OF EXPERIMENTAL SURGERY 1001-9030 23 5 537-539
WANG Xiangling et al. Construction of expressive vector containing double suicide genes controlled by MDR1 promoter and its expression in K562/A02 cell. (2006) JOURNAL OF SHANDONG UNIVERSITY. HEALTH SCIENCES 1671-7554 44 4 336-340
Miyagawa S et al. Angiogenic gene cell therapy using suicide gene system regulates the effect of angiogenesis in infarcted rat heart. (2006) TRANSPLANTATION 0041-1337 1534-6080 81 6 902-907
Song Yue et al. Procaspase-3 enhances in vitro effect of cytosine deaminase-thymidine kinase fusion disuicide gene therapy system on human ovarian carcinoma. (2005) Chinese Journal of Obstetrics and Gynecology 40 6 411-416
Kong Beihua et al. In vitro treatment of ovarian cancer cells with cytosine deaminase-thymidine kinase fusion disuicide gene therapy system under the control of human telomerase reverse transcriptase gene promoter. (2004) Chinese Journal of Obstetrics and Gynecology 39 6 390-395
Xie Na et al. Construction and Expression of a Fusion Suicide Gene FCU1 Vector Plasmid. (2004) Acta Medicinae Universitatis Scientiae et Technologiae Huazhong 1672-0741 33 4 419-422
Kis E et al. Microarray analysis of radiation response genes in primary human fibroblasts. (2006) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS 0360-3016 1879-355X 66 5 1506-1514,
1078453
Szakcikk (Folyóiratcikk) | Tudományos[1078453]
Ma Le et al. Positive Cofactor 4 as a Potential Radiation Biodosimeter for Early Assessment. (2022) DOSE-RESPONSE 1559-3258 1559-3258 20 1
Startseva Olga M. et al. Dimeric derivatives of chlorophyll a with fragments of oligoethylene glycols as spacers between macrocycles: Synthesis, dark and photoinduced cytotoxic activity. (2022) JOURNAL OF PORPHYRINS AND PHTHALOCYANINES 1088-4246 1099-1409 26 02 91-103
Breit Samuel N. et al. The GDF15-GFRAL Pathway in Health and Metabolic Disease: Friend or Foe?. (2021) Megjelent: Annual Review of Physiology pp. 127-151
Rassamegevanon Treewut et al. Molecular Response to Combined Molecular- and External Radiotherapy in Head and Neck Squamous Cell Carcinoma (HNSCC). (2021) CANCERS 2072-6694 13 22
Zhu Yaqiong et al. MicroRNA-155-5p regulates the Th1/Th2 cytokines expression and the apoptosis of group 2 innate lymphoid cells via targeting TP53INP1 in allergic rhinitis. (2021) INTERNATIONAL IMMUNOPHARMACOLOGY 1567-5769 1878-1705 101
Biolatti Vanesa et al. High-throughput meta-analysis and validation of differentially expressed genes as potential biomarkers of ionizing radiation-response. (2021) RADIOTHERAPY AND ONCOLOGY 0167-8140 1879-0887 154 21-28
Herskind Carsten et al. Gene Expression Profiles Reveal Extracellular Matrix and Inflammatory Signaling in Radiation-Induced Premature Differentiation of Human Fibroblast in vitro. (2021) FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY 2296-634X 2296-634X 9
Ding Lixin et al. Cdc25B is transcriptionally inhibited by IER5 through the NF-YB transcription factor in irradiation-treated HeLa cells. (2021) TOXICOLOGY RESEARCH 2045-452X 2045-4538 10 4 875-884
Wang Zhiqian et al. miR-142-5p and miR-212-5p cooperatively inhibit the proliferation and collagen formation of cardiac fibroblasts by regulating c-Myc/TP53INP1. (2020) CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 0008-4212 1205-7541 98 5 314-323
Cruz-Garcia Lourdes et al. In Vivo Validation of Alternative FDXR Transcripts in Human Blood in Response to Ionizing Radiation. (2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 1661-6596 1422-0067 21 21
Pan Li et al. IER5, a DNA damage response gene, is required for Notch-mediated induction of squamous cell differentiation. (2020) ELIFE 2050-084X 2050-084X 9